News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Accenture Announces $550 Million, 10-year Agreement with Bristol-Myers Squibb Company (BMY)



9/10/2008 9:24:10 AM

Contract Includes IT and Financial Support Services NEW YORK--(BUSINESS WIRE)--Accenture (NYSE: ACN) announced today that it has signed a new 10-year, $550 million agreement with Bristol-Myers Squibb for a range of finance and accounting and application development and maintenance services.

The “bundled” services agreement extends a four-year outsourcing agreement the two companies signed in 2004 for application maintenance and accounts payable services and expands the scope to include additional application maintenance services, application development services and global financial support services.

Accenture will provide these services to Bristol-Myers Squibb in the Americas, Asia, and EMEA regions in 22 languages through Accenture’s Global Delivery Network, which includes more than 50 delivery centers across five continents.

The agreement provides dedicated global IT and financial support services to Bristol-Myers Squibb to help achieve operational cost savings and flexibility. The agreement is also designed to enable Bristol-Myers Squibb to more effectively manage its business, by providing a variable cost structure to address varying economic factors, such as patent lifecycles.

“This agreement enables us to continue to leverage Accenture’s capabilities and integrate them with our Bristol-Myers Squibb employees, creating high performance teams to improve our productivity and support our strategic transformation to a next-generation BioPharma company,” said Paul von Autenried, vice president and CIO, Bristol-Myers Squibb. “It gives us greater flexibility, thereby allowing the company to focus on what we do best – discover and develop medicines that will help patients prevail in their fight against serious disease.”

Bob Easton, Accenture’s client account director for Bristol-Myers Squibb said, “The biopharmaceutical industry is undergoing significant change that requires new ways of doing business. Bristol-Myers Squibb has recognized that partnering with a single provider for multiple business functions allows it to improve business outcomes and achieve significant cost efficiencies through more strategic, streamlined operations.”

About Accenture

Accenture is a global management consulting, technology services and outsourcing company. Combining unparalleled experience, comprehensive capabilities across all industries and business functions, and extensive research on the world’s most successful companies, Accenture collaborates with clients to help them become high-performance businesses and governments. With more than 180,000 people in 49 countries, the company generated net revenues of US$19.70 billion for the fiscal year ended Aug. 31, 2007. Its home page is www.accenture.com.

Contacts

Accenture Benedict Payne, +44 (20) 7844 0440 benedict.j.payne@accenture.com or Geoffrey Pomerantz, +1 312-401-3143 geoffrey.pomerantz@accenture.com


Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES